ConductScience.org, home

Gene · 140738

NIH grants533

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleTMEM37 papersNewest fiscal year
P30CA016672Cancer Center Support Grant282025
P30CA008748Cancer Center Support Grant62025
P01CA065493Off-the-Shelf Immune Effector Cells for Hematological Malignancies32025
P01CA111412NK cells, their receptors and cancer therapy22025
P30CA006973Regional Oncology Research Center22025
P30CA016058Cancer Center Support Grant22025
P30CA062203Cancer Center Support Grant22025
P30EY008126Core Grant in Vision Research22025
P40OD010960Viper Resource Grant at Texas A&M University-Kingsville22025
P50CA126752SPORE in Lymphoma22025
R01CA155010Personal tumor neoantigens for immunity against chronic lymphocytic leukemia22025
R01GM102515RNA Structural Motif Analysis Revisited: Towards a Systematic Understanding of Noncoding RNA as Modular Biomolecules22025
R01HG006677Computational Methods for Gene Discovery, Genome Annotation, and Genome Assembly22025
R35GM130151Computational Methods for Microbial and Microbiome Sequence Analysis22025
ZIASC004020Vaccine and immunotherapy strategies for cancer and viruses causing cancer22025
K08NS123552Development of a Translational Research Platform to Understand and treat Defective Protein Trafficking in Childhood-Onset Hereditary Spastic Paraplegia12025
K12CA120780UNC Oncology K1212025
K24AI131924Expansion of research and mentoring opportunities to reduce the burden of maternal and pediatric HIV in Botswana12025
P01AI127338Harnessing the Power of Experimental Genetic Crosses to Probe Drug Resistance in Malaria12025
P01AI162242Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/140738/grants